Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
06/2007
06/20/2007EP1796657A2 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
06/20/2007EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
06/20/2007CN1984897A Light-emitting device material and light-emitting device
06/20/2007CN1982303A Water soluble anti-HIV component of lithospermum erythrorhizon and its extracts
06/20/2007CN1982302A Separation preparing method for high purity lactone of largehead atractylodes
06/20/2007CN1982301A A manufacturing process of 2',2'-difluoronucleoside and intermediate
06/20/2007CN1982296A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
06/20/2007CN1321638C Ligustilide oil and its preparation
06/19/2007US7232930 Compounds and methods for preparing methanesulfonamides
06/19/2007US7232817 α- and β-amino acid hydroxyethlamino sulfonyl urea derivatives useful as retroviral protease inhibitors
06/19/2007US7232811 Furosemide modulators of HM74
06/19/2007US7232616 Complex
06/14/2007WO2007067581A1 2-(n-methyl-propanamine)-3-(2-naphthol) thiophene, an impurity of duloxetine hydrochloride
06/14/2007WO2007066160A1 Process for the separation of optical isomers of the corey lactone
06/14/2007WO2007005455A3 Improved process for preparing (disubstitutedpropenyl) phenylalkyl substituted heterocycles
06/14/2007US20070135650 of dicarboxylic acids and/or derivatives in the presence of hydrogenation catalysts, to form butanediol (BDO), butyrolacetone (GBL) and tetrahydrofuran (THF)
06/14/2007US20070135648 Decarboxylation/hydroxylation without the release of carbon monoxide by using a mixed-oxide, supported, hydrogenation catalyst based on rhenium oxide with an absense of ruthenium and, in some cases, platinum and palladium; autoclaving malic acid to obtain hydroxybutyrolactone and 1,2,4-butanetriol
06/14/2007US20070135515 Method for producing sorbicillactone a
06/14/2007US20070135503 [(Alkyl-phenyl-furan-3-carbonyl)-amino]-phenyl-acetic acids; for treatment of headaches and migraines
06/14/2007US20070135498 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (1-hydroxymethyl-cyclopentyl)-amide; hypertension, atherosclerosis, unstable coronary syndrome, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, alzheimers
06/14/2007US20070135497 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient
06/14/2007US20070135496 Substituted benzylaminoalkylene heterocycles
06/14/2007US20070135490 Phenetanolamine derivatives
06/14/2007US20070135394 Process for the synthesis of vitamin d compounds and intermediates for the synthesis of the compounds
06/14/2007US20070135386 Novel Compounds and Compositions as Cathepsin Inhibitors
06/14/2007US20070134737 Fluorophore compounds and their use in biological systems
06/13/2007EP1795527A1 Carbamoyl-substituted spiro derivative
06/13/2007EP1794161A2 Muscarinic receptor antagonists
06/13/2007EP1794143A1 Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
06/13/2007EP1794140A2 Process for the preparation of citalopram and escitalopram
06/13/2007EP1794139A2 Substituted heterocyclic compounds and uses thereof
06/13/2007EP1794117A2 Mercaptoamides as histone deacetylase inhibitors
06/13/2007EP1794109A1 Process for the purification of 1, 4-butanediol
06/13/2007EP1532126B1 Method for producing tetrahydrofuran
06/13/2007EP1214292B1 Tyrosine derivatives
06/13/2007CN1980936A 2,4,6-phenylsubstituted cyclic ketoenoles.
06/13/2007CN1980894A Compounds and compositions as PPAR modulators.
06/13/2007CN1980892A Dpp-IV inhibitors
06/13/2007CN1978437A Andrographolide C15 substituted series derivates and their preparing method
06/13/2007CN1978051A Catalyst for alduronic gas-phase hydrogenation to prepare alditol and preparing method
06/13/2007CN1977837A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
06/13/2007CN1977836A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
06/13/2007CN1321115C Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma
06/13/2007CN1321101C New retinoids for the treatment of emphysema
06/12/2007US7230124 Prevent skin damage; therapy for skin disorders
06/12/2007US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
06/12/2007US7230020 For therapy of metabolic disorders, such as diabetes and obesity, cardiovascular disorders, such as hypertension, glaucoma, inflammatory disorders, such as arthritis or asthma, immune disorders, bone disorders, such as osteoporosis, cancer
06/12/2007US7229994 Analgesics; anxiolytic agents; gastrointestinal disorders
06/12/2007US7229988 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
06/12/2007US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes
06/12/2007US7229702 9,9-Dimethylfluorene trimers capped with N-(9-anthracenyl- or 9-phenanthrenyl)-N-p-tolylamine used to produce an organic light-emitting device that exhibits an extremely pure luminescent hue and has a light emission of high efficiency, high brightness, and long lifetime
06/12/2007CA2354023C Phenylglycine derivatives
06/07/2007WO2007064749A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007WO2007063974A1 Process for hydrogenating aromatic ring of aromatic ring compound
06/07/2007WO2007063925A1 2-aminobenzamide derivative
06/07/2007WO2007063086A1 Novel nk1 and nk2 antagonists
06/07/2007WO2007062996A1 3-amino-1-arylpropyl indoles and aza-substituted indoles
06/07/2007WO2007045420A3 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors
06/07/2007WO2007024744A3 Heterocyclic carboxamide compounds as steroid nuclear receptor ligands
06/07/2007US20070129561 Method for the separation of intermediates which may be used for the preparation of escitalopram
06/07/2007US20070129427 Novel compound and pharmaceutical composition
06/07/2007US20070129369 Heteroaryl substituted cyclohexyl-1,4-diamine compounds
06/07/2007US20070128555 polymerizable ester compound containing a fluorinated alkyl group, a lactone ring, and an acid-eliminatable unit within a common molecule can be polymerized into a polymer which meets water repellency as needed for the immersion lithography
06/07/2007CA2632922A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007CA2631693A1 Novel nk1 and nk2 antagonists
06/07/2007CA2629964A1 2-aminobenzamide derivative
06/07/2007CA2629962A1 3-amino-1-arylpropyl indoles and aza-substituted indoles
06/07/2007CA2628817A1 Iminopropene compound and use thereof
06/06/2007EP1792901A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
06/06/2007EP1792899A1 Process for production of optically active amine derivatives
06/06/2007EP1792613A2 Dicationic compounds which selectively recognize G-quadruplex DNA
06/06/2007EP1791825A1 Benzoyl-substituted serine amides
06/06/2007EP1791816A1 Iodine-phenyl-substituted cyclic cetoenols
06/06/2007EP1791807A1 Therapeutic diphenyl ether ligands
06/06/2007EP1187833B1 Method of producing thiamethoxam
06/06/2007DE102005056453A1 2-Methyl-3-(5-methyl-2-furyl)-butanal 2-methyl-3- (5-methyl-2-furyl) -butanal
06/06/2007CN1976914A 11-methyl-13-tridecanolide, 12-methyl-14-tetradeca- nolide and 13-methyl-15-pentadecanolide, perfume compositions containing the same, and process for the production of compounds including the same
06/06/2007CN1976912A Biphenyltetracarboxylic acid dianhydride, method for producing the same, polyimide using the same and method for producing the same
06/06/2007CN1976911A Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
06/06/2007CN1976710A Compounds and compositions as cathepsin S inhibitors
06/06/2007CN1976705A 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1H-pyrrolo not 2,3-C|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and dia
06/06/2007CN1976693A Transthyretin stabilization
06/06/2007CN1974564A Prepn process of Mycophenolate mofetil
06/06/2007CN1974009A Bifunctional chiral sacchariferous semicarbazide and thiocarbamide catalyst and its prepn process and application in asymmetric reaction
06/06/2007CN1319962C 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
06/06/2007CN1319961C Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
06/06/2007CN1319960C Method for making furfuraldehyde using xylose mother liquor as material
06/06/2007CN1319929C Aryl phenyl substituted cyclic ketoenols
06/05/2007US7227029 Reacting butyrolactone with methylamine; heating, pressurization
06/05/2007US7226935 Hypoglycemic agent
06/05/2007US7226930 Phosphodiesterase 4 inhibitors
06/05/2007CA2157586C Indoletetralins having dopaminergic activity
05/2007
05/31/2007WO2007060166A1 New n-phenethylcarboxamide derivatives
05/31/2007WO2007060164A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
05/31/2007WO2007060048A1 2-methyl-3-(5-methyl-2-furyl)butanal
05/31/2007WO2007025304A3 Process for preparing saccharinic acids and lactones
05/31/2007WO2007017687A3 Ep2 receptor agonists
05/31/2007WO2007017289A3 Acyltryptophanols for fertility control
05/31/2007WO2006113552A3 Cyanoarylamines
05/31/2007WO2006084056A3 Compounds and methods for modulating communication and virulence in quorum sensing bacteria